RAFAEL
BAÑARES CAÑIZARES
Catedrático de universidad
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (24)
2023
-
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode
Liver International, Vol. 43, Núm. 7, pp. 1548-1557
-
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
Gut, Vol. 72, Núm. 4, pp. 749-758
-
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome
Transplantation, Vol. 107, Núm. 6, pp. 1330-1340
-
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Hepatology (Baltimore, Md.), Vol. 77, Núm. 6, pp. 2052-2062
-
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
Digestive Diseases and Sciences, Vol. 68, Núm. 6, pp. 2731-2737
2022
-
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 10, pp. 2276-2286.e6
2021
-
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Journal of Hepatology, Vol. 75, Núm. 3, pp. 589-599
-
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis
Journal of Hepatology, Vol. 75, Núm. 2, pp. 342-350
-
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10
-
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
JHEP Reports, Vol. 3, Núm. 6
2020
-
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091
2019
-
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH
Gastroenterologia y Hepatologia, Vol. 42, Núm. 10, pp. 657-676
-
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
The Lancet, Vol. 393, Núm. 10181, pp. 1597-1608
2017
-
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Journal of Hepatology, Vol. 66, Núm. 6, pp. 1138-1148
-
Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver
Gastroenterologia y Hepatologia
2016
-
Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension
Hepatology, Vol. 63, Núm. 1, pp. 197-206
2013
-
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study
Hepatology, Vol. 58, Núm. 6, pp. 2079-2088
2010
-
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: Relevance of serum sodium concentration
Liver International, Vol. 30, Núm. 8, pp. 1137-1142
2009
2003
-
Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: A double-blind RCT
Hepatology, Vol. 37, Núm. 6, pp. 1260-1266